AavantiBio
Cambridge
About AavantiBio
AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $107.0M
- Funding stage: M&A
- Last round: Series A (Oct 2020)
- Website: aavantibio.com
Industries & Categories
Biotechnology, Genetics, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/aavantibio-50771 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.